Retatrutide is a newly developed therapy that acts as a potent GLP-1 receptor agonist. This breakthrough approach holds significant potential for regulating type 2 diabetes. By imitating the actions of natural GLP-1, Retatrutide enhances insulin secretion and suppresses glucagon release, leading to improved glycemic control. Clinical trials have de